The test of heterogeneity was not significant for eight studies (I2 = 39.03%, H2 = 1.64, p = 0.42); therefore, we used the fixed-effects model to compare the survivin expression between the serous and non-serous subtypes of ovarian carcinoma. Here, BIRC5 is linked to ovarian carcinoma.